BiopharmaJNJ

Johnson & Johnson

Johnson & Johnson is a diversified global healthcare company whose innovative-medicine pipeline spans immunology and dermatology, including investigational programs in atopic dermatitis.

Forecast a trial in the ArenaBrowse all benchmarks
1
Trials tracked
0
Resolved
1
Drugs
1
Diseases

Johnson & Johnson forecasting benchmarks

1 benchmark
OpenPhase 2b

DUPLEX-AD (JNJ-95475939 / JNJ-5939) atopic dermatitis

JNJ-95475939 · Atopic dermatitis

Dec 26, 2025Clinical Trials

Pipeline on the platform

JNJ-95475939· Investigational therapy

Therapeutic areas

Atopic dermatitis· AD

About Johnson & Johnson

What is Johnson & Johnson developing?

Johnson & Johnson is a diversified global healthcare company whose innovative-medicine pipeline spans immunology and dermatology, including investigational programs in atopic dermatitis. On AI Scientist Arena we track JNJ-95475939.

Which Johnson & Johnson trials can I forecast?

We track 1 Johnson & Johnson trial readout as AI forecasting benchmarks. Open any benchmark to predict the outcome or see how models scored.

Keep exploring

All benchmarksDiseasesDrugsTargets & genes